Home NDC 0173-0893 Trelegy Ellipta
Product NDC 0173-0893
11-digit product format 001730893
Labeler code 0173
Product ID 0173-0893_3adf47cb-c3b5-4fdb-9441-d90679b79687
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name fluticasone furoate, umeclidinium bromide and vilanterol trifenatate
Dosage form POWDER
Route RESPIRATORY (INHALATION)
Labeler GlaxoSmithKline LLC
Application NDA209482
Marketing category NDA
Marketing start 2020-09-09
Substance FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
Active strength 200; 62.5; 25 ug/1; ug/1; ug/1
Pharmacologic classes Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209482-001 TRELEGY ELLIPTA FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 N209482-002 TRELEGY ELLIPTA FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09
Orange Book patents# Current patent rows page 1 of 1 · 15 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209482-001 7488827 2027-12-18 Drug substance, Drug product 2017-10-06 N209482-001 8534281 2030-03-08 Drug product 2017-10-06 N209482-001 8534281*PED 2030-09-08 Pediatric extension N209482-001 8746242 2030-10-11 Drug product 2017-10-06 N209482-001 11090294 2030-11-29 U-3202 2021-09-14 N209482-001 12396986 2030-11-29 Drug product 2025-09-18 N209482-001 9750726 2030-11-29 Drug product 2017-10-06 N209482-001 8746242*PED 2031-04-11 Pediatric extension N209482-002 7488827 2027-12-18 Drug substance, Drug product 2020-10-06 N209482-002 8534281 2030-03-08 Drug product 2020-10-06 N209482-002 8534281*PED 2030-09-08 Pediatric extension N209482-002 8746242 2030-10-11 Drug product 2020-10-06 N209482-002 12396986 2030-11-29 Drug product 2025-09-18 N209482-002 9750726 2030-11-29 Drug product 2020-10-06 N209482-002 8746242*PED 2031-04-11 Pediatric extension
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 80 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N209482-002 TRELEGY ELLIPTA 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2020-09-09 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N209482-001 TRELEGY ELLIPTA 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2017-09-18 782e0a99824c…
Observed Orange Book patent history# Patent history page 1 of 34 · 1,346 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N209482-001 7488827 2027-12-18 Drug substance, Drug product 2017-10-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-001 8534281 2030-03-08 Drug product 2017-10-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-001 8534281*PED 2030-09-08 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-001 8746242 2030-10-11 Drug product 2017-10-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-001 11090294 2030-11-29 U-3202 2021-09-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-001 12396986 2030-11-29 Drug product 2025-09-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-001 9750726 2030-11-29 Drug product 2017-10-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-001 8746242*PED 2031-04-11 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-002 7488827 2027-12-18 Drug substance, Drug product 2020-10-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-002 8534281 2030-03-08 Drug product 2020-10-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-002 8534281*PED 2030-09-08 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-002 8746242 2030-10-11 Drug product 2020-10-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-002 12396986 2030-11-29 Drug product 2025-09-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-002 9750726 2030-11-29 Drug product 2020-10-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209482-002 8746242*PED 2031-04-11 Pediatric extension caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209482-001 7488827 2027-12-18 Drug substance, Drug product 2017-10-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-001 8534281 2030-03-08 Drug product 2017-10-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-001 8534281*PED 2030-09-08 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-001 8746242 2030-10-11 Drug product 2017-10-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-001 11090294 2030-11-29 U-3202 2021-09-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-001 12396986 2030-11-29 Drug product 2025-09-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-001 9750726 2030-11-29 Drug product 2017-10-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-001 8746242*PED 2031-04-11 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-002 7488827 2027-12-18 Drug substance, Drug product 2020-10-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-002 8534281 2030-03-08 Drug product 2020-10-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-002 8534281*PED 2030-09-08 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-002 8746242 2030-10-11 Drug product 2020-10-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-002 12396986 2030-11-29 Drug product 2025-09-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-002 9750726 2030-11-29 Drug product 2020-10-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209482-002 8746242*PED 2031-04-11 Pediatric extension 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-001 7498440 2025-04-27 Drug substance, Drug product 2017-10-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-001 8309572 2025-04-27 U-2129 2017-10-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-001 7439393 2025-05-21 U-2127 Drug substance, Drug product 2017-10-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-001 7439393 2025-05-21 U-2957 Drug substance, Drug product 2017-10-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-001 8183257 2025-07-27 U-2128 2017-10-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-001 8183257 2025-07-27 U-2129 2017-10-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-001 7439393*PED 2025-11-21 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-001 7488827 2027-12-18 Drug substance, Drug product 2017-10-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-001 8534281 2030-03-08 Drug product 2017-10-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209482-001 8534281*PED 2030-09-08 Pediatric extension 31067a03dcf5…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 47 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Trelegy Ellipta
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength FLUTICASONE FUROATE 200 ug/1 UMECLIDINIUM BROMIDE 62.5 ug/1 VILANTEROL TRIFENATATE 25 ug/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7AN603V4JV Internal UNII lookup 40AHO2C6DG Internal UNII lookup JS86977WNV Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 8 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1945039 Internal RxNorm lookup 1945044 Internal RxNorm lookup 1945047 Internal RxNorm lookup 1945048 Internal RxNorm lookup 2395769 Internal RxNorm lookup 2395771 Internal RxNorm lookup 2395774 Internal RxNorm lookup 2395775 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0173-0893 TRELEGY ELLIPTA (FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE) POWDER [GLAXOSMITHKLINE LLC] 12 Current NDC, Legacy NDC, 6 package rows 20240302_b5a81d5a-4648-4c7a-951d-33c014a63c7e.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Trelegy Ellipta FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE GlaxoSmithKline LLC b5a81d5a-4648-4c7a-951d-33c014a63c7e 2023-06-02 Warnings, Adverse reactions Exact identifier application applno (NDA): 209482 application number: NDA209482 ndc (product): 0173-0893
DailyMed RxNorm Mappings# RxCUI, RxNorm string, TTY table RxCUI RxNorm string TTY DailyMed SPL version 1945039 fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 Blisters PSN b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 1945047 fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUA PSN b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395769 fluticasone furoate 200 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT PSN b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395774 fluticasone furoate 200 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT PSN b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 1945044 TRELEGY ELLIPTA 100 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 14 Blisters PSN b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 1945048 TRELEGY ELLIPTA 100 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 30 Blisters PSN b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395771 TRELEGY ELLIPTA 200 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 14 Blisters PSN b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395775 TRELEGY ELLIPTA 200 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 30 Blisters PSN b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 1945044 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy] SBD b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395771 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy] SBD b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 1945048 30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy] SBD b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395775 30 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy] SBD b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 1945039 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler SCD b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395769 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler SCD b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 1945047 30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler SCD b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395774 30 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler SCD b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 1945039 fluticasone furoate 100 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT SY b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 1945047 fluticasone furoate 100 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT SY b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395769 fluticasone furoate 200 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT SY b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395774 fluticasone furoate 200 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT SY b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 1945044 Trelegy Ellipta (fluticasone furoate 100 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT) Dry Powder Inhaler, 14 ACTUAT SY b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 1945048 Trelegy Ellipta (fluticasone furoate 100 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT) Dry Powder Inhaler, 30 ACTUAT SY b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395771 Trelegy Ellipta (fluticasone furoate 200 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT) Dry Powder Inhaler, 14 ACTUAT SY b5a81d5a-4648-4c7a-951d-33c014a63c7e 14 2395775 Trelegy Ellipta (fluticasone furoate 200 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT) Dry Powder Inhaler, 30 ACTUAT SY b5a81d5a-4648-4c7a-951d-33c014a63c7e 14
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0173-0893-10 00173089310 1 TRAY in 1 CARTON (0173-0893-10) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER 1 tray 2020-09-09 0000-00-00 No No Current 0173-0893-14 00173089314 1 TRAY in 1 CARTON (0173-0893-14) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER 1 tray 2020-09-09 0000-00-00 No No Current 0173-0893-61 00173089361 1 TRAY in 1 CARTON (0173-0893-61) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER 1 tray 2020-09-09 0000-00-00 Yes No Current